Baird Financial Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,543
Closed -$397K 1869
2022
Q2
$397K Buy
5,543
+866
+19% +$63.3K ﹤0.01% 1432
2022
Q1
$379K Sell
4,677
-7,066
-60% -$598K ﹤0.01% 1533
2021
Q4
$1.21M Sell
11,743
-46,819
-80% -$4.5M ﹤0.01% 1129
2021
Q3
$5.12M Buy
58,562
+36,369
+164% +$3.29M 0.01% 591
2021
Q2
$1.99M Buy
22,193
+7,504
+51% +$634K 0.01% 926
2021
Q1
$1.11M Buy
+14,689
New +$1.11M ﹤0.01% 1088

Other funds holding SYNH

Baird Financial Group's SYNH Position: Q3 2022 in Review

Baird Financial Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 5,543 shares — an estimated $397K sold.

Baird Financial Group first reported a position in SYNH in Q1 2021 and held it in 6 quarters. The position peaked at $5.12M in Q3 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Baird Financial Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 5,543 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $397K.
  • Baird Financial Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 6 quarters.
  • Baird Financial Group's Syneos Health, Inc. Class A Common Stock position peaked at $5.12M in Q3 2021.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.